Tech Company Financing Transactions

Zosano Pharma Funding Round

Zosano Pharma closed a $30 million funding round on 7/7/2009. Investors included Nomura Phase4 Ventures, HBM Healthcare Investments and New Enterprise Associates.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

34790 Ardentech Ct.
Fremont, CA 94555
USA

Phone

(510) 745-1200

Website

www.zosanopharma.com

Email Address

[email protected]

Overview

Zosamo Pharma (NASDAQ: ZSAN) is a specialty pharmaceutical company focused on the development of novel proprietary products via the Macroflux technology.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Walker

        

Chief Financial Officer

Gregory Kitchener

        

Chief Medical Officer

Donald Kellerman

        

VP - Operations

Hayley Lewis

        

Browse more venture capital transactions:

Prev: 7/7/2009: Nexus Biosystems venture capital transaction
Next: 7/7/2009: Relievant Medsystems venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary